期刊文献+

全髋关节置换术后深静脉血栓发生的随机对照研究 被引量:15

A randomized controlled study on deep vein thrombosis after total hip arthroplasty
原文传递
导出
摘要 目的通过随机对照研究,探讨全髋关节置换术后深静脉血栓形成的发生率和预防措施。方法2007年5月至2008年12月行全髋关节置换术的141例患者,男53例,女88例;年龄17-86岁,平均(63.20213.78)岁。根据是否使用低分子肝素随机分成抗凝组(82例)和非抗凝组(59例),术后均行患肢深静脉顺行性造影,明确血栓发生的部位、大小及数量。诊断标准根据1972年Rabinov和Paulin提出的诊断标准,结合国内吕厚山的相关经验进行统一诊断。根据下肢血栓的部位将血栓分为中央型、周围型和混合性血栓。结果全髋关节置换术后深静脉血栓形成的发生率为32.62%(46例),其中中央型1例,混合型2例,周围型43例。临床症状有小腿后侧疼痛,沉重或紧张,足和踝关节周围轻度肿胀。临床体征有肌肉压痛、Homans征或Neuhof征阳性。将症状和体征都作为临床依据,其中无临床依据者共34例,占73.9%。抗凝组(82例)和非抗凝组(59例)深静脉血栓形成发生率的差异无统计学意义。结论采用数字化下肢深静脉造影技术能准确地发现全髋关节置换术后深静脉血栓形成,临床症状与其无直接关联,低分子肝素抗凝后虽能降低深静脉血栓形成的发生率,但差异无统计学意义。 Objective To investigate the incidence rate and prevention of deep vein thrombosis (DVT) after total hip arthroplasty (THA). Methods From May 2007 to Deeember 2008, 141 patients with THA underwent deep vein anterograde venography of lower limb in order to find the location, size and number of thrombus. There were 53 males and 88 females in our study. The patients ranged from 17 to 86 years old, with an average age of (63.20±13.78) years. The patients were randomly divided into antieoagulation group and non-antieoagulation group aeeording to the use of low-molecular-weight heparin (LMWH) or not. There were 82 patients in non-antieoagulation group and 59 ptients in non-antieoagulation group. The diagnosis of DVT was according to the criterion recommended by Rabinov and Paulin in 1972, eombining with the experience of the civil scholars. Depending on the finding of deep vein anterograde venography, the DVT was elassified into proximal type, distal and mixed ones. Results The incidenee rate of DVT after THA was 32.62% (46 patients). There were proximal DVT in one ease, mixed DVT in two eases, distal DVT in 43 eases. Thirty-four patients (73.9%) had not obvious elinieal signs and symptoms. There was no difference in ineidenee rate between the non-anticoagulation group (59 patients) and anticoagulation group (82 patients). Conclusion The ineident of DVT after THA can be found accurately by digital lower limb venography technology. There is no direct relation between clinical DVT and elinieal evidence. LHMN can decrease the incident rate, but there is no statistical significance. It is necessary to adopt individual thromboembolism prophylaxis measures.
出处 《中华骨科杂志》 CAS CSCD 北大核心 2010年第4期381-385,共5页 Chinese Journal of Orthopaedics
基金 国家自然科学基金面上项目(30973046)
关键词 关节成形术 置换 静脉血栓 随机对照试验 Arthroplasty, replacement, Hip Venous thrombosis Randomized controlled trials
  • 相关文献

参考文献13

  • 1Rabinov K,Paulin S.Roentgen diagnosis of venous thrombosis in the leg.Arch Surg,1972,104(2):134-144.
  • 2Geerts WH,Bergqvist D,Pined GF,et al.Prevention of venous thromboembolism:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).Chest,2008,133(6 Suppl):S381-453.
  • 3邱贵兴,杨庆铭,余楠生,翁习生,王凯,李晓林.低分子肝素预防髋、膝关节手术后下肢深静脉血栓形成的多中心研究[J].中华骨科杂志,2006,26(12):819-822. 被引量:431
  • 4O'Reilly RF,Burgess IA,Zieat B.The prevalence of venous thromboembolism after hip and knee replacement surgery.Med J Aust,2005,182(4):154-159.
  • 5Ebell MH.Evaluation of the patient with suspected deep vein thrombosis.J Fam Pract,2001,50(2):167-171.
  • 6Mesko JW,Brand RA,Iorio R,et al.Venous thromboembolic disease management patterns in total hip arthroplasty and total knee arthroplasty patients:a survey of the AAHKS membership.J Arthroplasty,2001,16(6):679-688.
  • 7Fitzgerald RH Jr,Spiro TE,Trowbridge AA,et al.Prevention of venous thromboembolic disease following primary total knee arthroplasty.A randomized,muhicenter,open-label,parallelgroup comparison of enoxaparin and warfarin.J Bone Joint Surg(Am),2001,83(6):900-906.
  • 8Freedman KB,Brookenthal KR,Fitzgerald RH Jr,et al.A metaanalysis of thremboembolic prophylaxis following elective total hip arthroplasty.J Bone Joint Surg(Am),2000,82(7):929-938.
  • 9Stem SH,Wixson RL,O'Connor D.Evaluation of the safety and efficacy of enoxaparin and warfarin for prevention of deep vein thrombosis after total knee arthroplasty.J Arthroplasty,2000,15 (2):153-158.
  • 10Levine MN,Raskob G,Beyth RJ,et al.Hemorrhagic complications of anticoagulant treatment:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest,2004,126(3 Suppl):S287-310.

二级参考文献28

  • 1熊长明,何建国,柳志红,程显声.低分子量肝素致血小板减少一例[J].中国循环杂志,2005,20(6):414-414. 被引量:4
  • 2Kyrle PA,Eiehinger S.Deep vein thrombosis.Lancet,2005,365:1163-1174.
  • 3Lowe GD,Haverkate F,Thompson SG,et al.Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables:the ECAT DVT Study.Thromb Haemost,1999,81:879-886.
  • 4Svensson PJ,Benoni G,Fredin H,et al.Female gender and resistance to activated protein C as potential risk factors for thrombosis after elective hip atthroplasty.Thromb Haemost,1997,78:993-996.
  • 5Kiyoshige Y,Kure S,Goto K,et al.Inherited risk factors for deep venom thrombosis following total hip arthroplasty in Japanese patients:matched control study.J Orthop Sci,2007,12:118-122.
  • 6De Stefano V,Rossi E,Pacioroni K,et al.Different circumstances of the first,first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene.Haematoligica,2003,88:61-66.
  • 7Corral J,Gonzalez-Conejero B,Lozano ML,et al.The venousthrombosis risk factor 20210A allele of the prothrombin gone is not a major risk factor for arterial thrombotic disease.Br J Haematol,1997,99:304-307.
  • 8Wells PS,Anderson JL,Scarcelis DK,et al.Factor ⅩⅢ Va134Leu variant is protective against venous thromboembolism:a Huge review and meta-analysis.Am J Epideminl,2006,164:101-109.
  • 9Ariens RA,Lai TS,Weisel JW,et al.Role of factor ⅩⅢ in fibrin clot formation and effects of genetic polymorphisms.Blood,2002,100:743-754.
  • 10Emmerich J,Vossen CY,Callas PW,et al.Chronic venous abnormalities in symptomatic and esymptomatic protein C deficiency.J Thromb Haemost,2005,3:1428-1431.

共引文献445

同被引文献221

引证文献15

二级引证文献186

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部